S-KIT Smart Breath Analyzer

Portable breath analyzer for non-invasive detection and measurement of volatile organic compounds and biomarkers in exhaled breath. Applicable in respiratory diagnostics, metabolic screening, and point-of-care testing environments. Provides rapid analysis with minimal patient preparation required.

A breath analysis system available in three configurations: CA3478 (NO+H2+CO2), CA3138 (NO+H2S+CO2), and CA4458 (NO+H2S+H2+CH4+CO2+O2) for combined assessment of inflammation and intestinal microbiota. The device is applicable in digestive and oral clinics, pediatrics, physical examinations, and allergy departments for diagnosis of conditions including irritable bowel syndrome, inflammatory bowel disease, colorectal cancer, Helicobacter pylori infection, functional dyspepsia, liver disease, halitosis, and allergic rhinitis/asthma.

A multi-molecular breath analysis system that detects NO, H2S, H2, CH4, CO, CO2, and O2 for simultaneous assessment of intestinal inflammation and microbiota status. It features olfactory AI and multimodal diagnostic capabilities. The device is designed for use in gastroenterology, pediatrics, physical examinations, and allergy departments, and is indicated for conditions including irritable bowel syndrome, inflammatory bowel disease, colorectal cancer, Helicobacter pylori infection, functional dyspepsia, liver disease, and allergic rhinitis/asthma.

A wearable device that performs laboratory-level analysis of biomarkers in breath samples in near-real-time. Based on headspace gas chromatography technology, it enables on-site measurement of metabolic markers including fat combustion indicators. Developed through 15+ years of research at ETH Zurich.

A breath analysis device for multi-molecular, multi-site, multi-parameter testing of respiratory and digestive conditions with complications. The CA series includes inflammatory phenotyping breath testing with NO baseline plus CO and H2S optional configurations, supporting online standard, offline, and tidal breath modes. It features breath quality control with standard gas and self-calibration, and is applicable to respiratory, pediatric, otolaryngology, surgery, radiology, and health screening departments for conditions including asthma, COPD, interstitial lung disease, lung cancer, chronic cough, allergic rhinitis, sinusitis, nasal polyps, radiation pneumonitis, and perioperative pulmonary complications.

A breath testing device designed for clinics, pharmacies, health screening centers, nursing homes, and community settings. It uses the same gas detection technology as hospital systems with interconnected diagnostic and treatment services, enabling hierarchical diagnosis and treatment of chronic respiratory diseases and cardiopulmonary health screening. It provides FeNO/CaNO/FeCO/FnNO testing for cough and asthma patients to optimize medication selection, reduce acute exacerbations and emergency hospitalization, and for susceptible populations for risk warning and disease prevention.

A multi-molecular, multi-site, multi-parameter breath analysis system for detecting inflammation and related conditions. The CA series includes multiple configurations (CA3478, CA3138, CA4458) that measure various exhaled gases including NO, CO, H2S, CH4, CO2, and O2 in different combinations. It supports online and offline sampling modes with quality control features, and is designed for respiratory, pediatric, ENT, surgical, radiology, and physical examination departments to diagnose conditions such as asthma, COPD, interstitial lung disease, lung cancer, chronic cough, allergic rhinitis, sinusitis, and perioperative pulmonary complications.

An advanced breath analysis device for multi-molecular, multi-parameter inflammation and bacterial microbiota testing. The DA series includes configurations such as DA2123 with variable flow rate multi-parameter testing and DA7349 with NO, H2S, H2, CH4, CO, CO2, and O2 for comprehensive inflammation and microbiota breath testing plus AI olfactory diagnosis. It is designed for respiratory, digestive, allergy, and immunology departments for academic research and clinical applications including allergic rhinitis, asthma, irritable bowel syndrome, inflammatory bowel disease, colorectal cancer, and gut-lung, gut-heart, gut-liver, and gut-brain axis dysbiosis conditions.

An advanced multi-molecular breath analysis system featuring variable flow rate measurements and AI olfactory diagnostics. The DA series (DA2123 and DA7349 models) measures multiple exhaled gases including NO, H2S, H2, CH4, CO, CO2, and O2 for comprehensive inflammation and microbiota assessment. It is designed for respiratory, digestive, allergy, and immunology departments for academic research and high-level clinical services, addressing conditions related to microbiota imbalance and inflammation-related diseases.

Diagnostic instrument for analyzing exhaled breath gases in clinical and research settings. Utilized for hydrogen breath testing and other respiratory diagnostic procedures.

A breath analyzer designed for patients with chronic respiratory diseases and susceptible populations, equipped with a mobile application and detection diagnostic treatment service card. It uses the same gas detection technology as hospital systems with interconnected diagnostic and treatment services, providing FeNO/FnNO self-testing for chronic cough and asthma patients to reduce acute exacerbations and emergency hospitalization, and for susceptible populations to reduce disease onset risk and progression to chronic disease.

A home-use breath analyzer designed for patients with chronic respiratory diseases and susceptible populations, featuring a mobile application and detection diagnostic treatment service card. It offers FeNO/FnNO self-testing capabilities using hospital-grade gas detection technology with interconnected diagnostic services, enabling chronic respiratory disease patients to reduce acute exacerbations and emergency hospitalization, and susceptible populations to reduce disease development risk.